Home Actithera

Actithera

In operation
Series A
Small Molecule Oral Drug Developer

Basic Information

Actithera is a molecular radiotherapy company specializing in biotechnology research services. The company focuses on utilizing radioactive isotopes associated with specific molecules to improve cancer treatment, aiming to deliver radiation directly and precisely to cancer cells. It also develops radiopharmaceuticals that enable consumers to receive concentrated radiation targeting cancer cells while minimizing harm to healthy tissues.
Actithera Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2021
info@actithera.com